Immunoglobulin VH chain gene analysis of peripheral blood IGM-producing B cells in patients with Kawasaki disease

Yonsei Medical Journal

Volumn 50, Issue 4, 2009, Pages 493-504

  Lee, Hyun Hee ^a   Shin, Jun Soo ^b   Kim, Dong Soo ^b  

^a Catholic Kwandong University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

B cell; Conventional antigen; Kawasaki disease; Oligoclonal expansion; Superantigen

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN M; SUPERANTIGEN;

ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL ACTIVATION; CELL CLONE; CELLULAR DISTRIBUTION; CHILD; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GERM LINE; HUMAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; T LYMPHOCYTE;

B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOGLOBULIN M; IMMUNOGLOBULIN VARIABLE REGION; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 70449719198     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2009.50.4.493     Document Type: Article

References (25)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: Clinical observations of 50 cases. Jpn J Allergol 1967;16:178-222.
2. Freeman AF, Shulman ST. Recent developments in Kawasaki disease. Curr Opin Infect Dis 2001;14:357-361
3. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, et al. Selective expansion of T cells expressing T-Cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A 1992;89:4066-4070
4. Leung DY, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993;342:1385-1388
5. Rowley AH, Eckerley CA, Jäck HM, Shulman ST, Baker SC. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol 1997;159:5946-5955
6. Andersson U. Development of B lymphocyte function in childhood. Acta Paediatr Ascand 1985;74:568-573
7. Andersson U, Bird AG, Britton BS, Palacios R. Humoral and cellular immunity in humans studied at the cell level from birth to two years of age. Immunol Rev 1981;57:1-38. (Pubitemid 11001859)
8. Council on Cardiovascular Disease in the Young, Committee on Rheumatic Fever, and Kawasaki Disease, American Heart Association. Diagnostic guidelines for Kawasaki disease. Circulation 2001;103:335-336
9. Brezinschek HP, Brezinschek RI, Lipsky PE. Analysis of the heavy chain repertoire of human peripheral B cells using singlecell polymerase chain reaction. J Immunol 1995;155:190-202.
10. Meissner HC, Leung DY. Superantigens, conventional antigens and the etiology of Kawasaki syndrome. Pediatr Infect Dis J 2000;19:91-94
11. Rowley AH. The etiology of Kawasaki disease: superantigen or conventional antigen? Pediatr Infect Dis J 1999;18:69-70.
12. Leucht S, Uttenreuther-Fischer MM, Gaedicke G, Fischer P. The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of V(H) 3-23 and 3-30/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy. Clin Immunol 2001;99:18-29. (Pubitemid 32324641)
13. Duong TT, Silverman ED, Bissessar MV, Yeung RS. Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease. Int Immunol 2003; 15:79-89.
14. Choi IH, Chwae YJ, Shim WS, Kim DS, Kwon DH, Kim JD, et al. Clonal expansion of CD8+ T cells in Kawasaki disease. J Immunol 1997;159:481-486 (Pubitemid 127493735)
15. Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol 2001;166:1334-1343
16. Rowley AH, Baker SC, Orenstein JM, Shulman ST. Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight. Nat Rev Microbiol 2008;6:394-401.
17. Barron K, DeCunto C, Montalvo J, Orson F, Lewis D. Abnormalities of immunoregulation in Kawasaki syndrome. J Rheumatol 1988;15:1243-1249
18. Leung DY, Geha RS, Newburger JW, Burns JC, Fiers W, Lapierre LA, et al. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med 1986;164:1958-1972 (Pubitemid 17217976)
19. Leung DY. The potential role of cytokine-mediated vascular endothelial activation in the pathogenesis of Kawasaki disease. Acta Paediatr Jpn 1991;33:739-744
20. Lee TJ, Kim KH, Chun JK, Kim DS. Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease. Yonsei Med J 2008;49:714-718
21. Hillson JL, Karr NS, Oppliger IR, Mannik M, Sasso EH. The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A. J Exp Med 1993;178:331-336 (Pubitemid 23173268)
22. Silverman GJ. Unconventional B-cell antigens and human immune repertoires. Ann N Y Acad Sci 1995;764:342-355
23. Jukes TH, King JL. Evolutionary nucleotide replacements in DNA. Nature 1979;281:605-606
24. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL, Weigert MG. The role of clonal selection and somatic mutation in autoimmunity. Nature 1987;328:805-811 (Pubitemid 17118532)
25. Shlomchik MJ, Nemazee DA, Sato VL, Van Snick J, Carson DA, Weigert MG. Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells. J Exp Med 1986;164:407-427